AzTrials
AzTrials

TraumaPhase 3NCT01760135

Nutritional Requirement for the Severe Trauma Patients

A Phase 3 study testing high caloric nutritional supplement and low caloric nutritional supplement in people with Trauma, run by Asan Medical Center at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

After severe trauma, high caloric nutrition supplement do harm on metabolic and immunologic aspects. Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Trauma
What is being tested?
high caloric nutritional supplement and low caloric nutritional supplement
Could I receive a placebo?
No, everyone receives an active treatment
How many people
61 participants
Where
1 siteSouth Korea
Study dates
Nov 2012to Nov 2013
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ISS more than 15 score
  • older than 20 years old
  • patient who need parenteral nutrition more than 5 days

Who cannot join

  • patients who have metabolic disease except for diabetes
  • patients who cannot resuscitated
  • very low body weight (< 40kg)

Trial locations and contacts

1 site in 1 country.

Suk-Kyung Hong, MD., PhD. contact

82-2-3010-5989

skhong94@amc.seoul.kr

South Korea1 site, 1 recruiting
  • Asan Medical Center

    Seoul, 138-736

    Suk-Kyung Hong, MD., PhD., 82-2-3010-5989, skhong94@amc.seoul.kr

    Recruiting

Other trials in South Korea

About this study

After severe trauma, high caloric nutrition supplement do harm on metabolic and immunologic aspects.

Conditions
Trauma
Being tested
high caloric nutritional supplement, low caloric nutritional supplement
Keywords
trauma, nutrition, hyperglycemia
Medical subject headings
Wounds and Injuries, Hyperglycemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • high caloric nutritional supplementDietary supplement

    high caloric nutritional supplement (25kcal/kg)

  • low caloric nutritional supplementDietary supplement

    low caloric nutritional supplement(15kcal/kg)

Study groups in NCT01760135
Study groupRoleWhat they receive
low caloryExperimental15kcal/kg caloric supplement
Receives: Dietary Supplement: high caloric nutritional supplement
high caloryActive comparator25kcal/kg
Receives: Dietary Supplement: low caloric nutritional supplement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of antibiotics usage (days)

    Measured: participants will be followed for the duration of hospital stay, an expected average of 2 week).

Secondary outcomes (4)
  1. Mortality

    Measured: participants will be followed for the duration of hospital stay, an expected average of 2 week

  2. Number of date when is showing hyperglycemia (more than 200mg/dL)

    Measured: participants will be followed for the duration of hospital stay, an expected average of 2 week

  3. Hospitals stays

    Measured: participants will be followed for the duration of hospital stay, an expected average of 2 week

  4. ICU stays

    Measured: participants will be followed for the duration of hospital stay, an expected average of 2 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jan 2013 (estimated)
  2. Study startNov 2012
  3. Primary completionNov 2013 (estimated)
  4. Study completionNov 2013 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
61 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01760135
Sponsor's protocol ID
2012-001
Status last verified
Jan 2013
First submitted
21 Dec 2012
Last updated
4 Jan 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing high caloric nutritional supplement and low caloric nutritional supplement in people with Trauma, run by Asan Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Jan 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Suk-Kyung Hong, MD., PhD. (82-2-3010-5989, skhong94@amc.seoul.kr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of antibiotics usage (days) (time frame: participants will be followed for the duration of hospital stay, an expected average of 2 week).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jan 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in